BioCentury
  • Company Profiles
  • Target Profiles
  • Product Profiles
Explore BCIQ profiles by entering a target name.
BioCentury | Mar 26, 2024
Distillery Therapeutics

Targeting MMP8 for depression

BioCentury | Aug 10, 2023
Distillery Therapeutics

RNF41 gene therapy for chronic liver disease

BioCentury | Jan 7, 2022
Distillery Therapeutics

C1QTNF3 identified as target in tendinopathy

BioCentury | Oct 20, 2020
Deals

Oct. 19 Quick Takes: Genesis, Genentech in AI drug discovery deal; plus Endo-BioSpecifics, Gemini, Catalyst-Jacobus, ONK, Venclexta  

Genesis and Genentech collaborate to identify drug candidates using AIStanford spinout and AI platform company Genesis Therapeutics Inc. entered into a collaboration agreement with the
BioCentury | Jul 10, 2020
Finance

How buysiders are sizing up commercial launches during the pandemic

Buysiders defining new rules for analyzing product launches in the world of virtual sales
BioCentury | Jun 20, 2018
Distillery Techniques

Drug platforms

Items per page:
1 - 10 of 262